159 related articles for article (PubMed ID: 35538716)
41. [New and established indications for phototherapy with narrowband UVB].
Berneburg M; Brod C; Benedix F; Röcken M
J Dtsch Dermatol Ges; 2005 Nov; 3(11):874-82. PubMed ID: 16232274
[TBL] [Abstract][Full Text] [Related]
42. Clinical and Spectrophotometric Evaluation of Skin Photoadaptation in Vitiligo Patients after a Short Cycle of NB-UVB Phototherapy.
Arisi M; Rossi MT; Fusano M; Gualini A; Tomasi C; Moggio E; Caravello S; Calzavara-Pinton P; Venturini M
Dermatology; 2019; 235(6):509-515. PubMed ID: 31586997
[TBL] [Abstract][Full Text] [Related]
43. A review of phototherapy protocols for psoriasis treatment.
Lapolla W; Yentzer BA; Bagel J; Halvorson CR; Feldman SR
J Am Acad Dermatol; 2011 May; 64(5):936-49. PubMed ID: 21429620
[TBL] [Abstract][Full Text] [Related]
44. Narrow-band ultraviolet B phototherapy for early stage mycosis fungoides.
Xiao T; Xia LX; Yang ZH; He CD; Gao XH; Chen HD
Eur J Dermatol; 2008; 18(6):660-2. PubMed ID: 18955199
[TBL] [Abstract][Full Text] [Related]
45. Clinical evaluation of interrupted versus continuous narrowband ultraviolet B phototherapy in nonsegmental vitiligo treatment: A prospective randomized comparative study.
Anbar TS; Mohammed SS; Mohamed DM; Abdel-Rahman AT
Dermatol Ther; 2019 Nov; 32(6):e13117. PubMed ID: 31606939
[TBL] [Abstract][Full Text] [Related]
46. What Is New in Narrow-Band Ultraviolet-B Therapy for Vitiligo?
Khanna U; Khandpur S
Indian Dermatol Online J; 2019; 10(3):234-243. PubMed ID: 31149564
[TBL] [Abstract][Full Text] [Related]
47. Effective treatment of psoriasis with narrow-band UVB phototherapy is linked to suppression of the IFN and Th17 pathways.
Rácz E; Prens EP; Kurek D; Kant M; de Ridder D; Mourits S; Baerveldt EM; Ozgur Z; van IJcken WF; Laman JD; Staal FJ; van der Fits L
J Invest Dermatol; 2011 Jul; 131(7):1547-58. PubMed ID: 21412260
[TBL] [Abstract][Full Text] [Related]
48. Transcriptome profiling in psoriasis: NB-UVB treatment-associated transcriptional changes and modulation of autoinflammation in perilesional skin in early-phase disease.
Vacharanukrauh P; Meephansan J; Ponnikorn S; Tangtanatakul P; Soonthornchai W; Wongpiyabovorn J; Ingkaninanda P; Morita A
J Dermatol Sci; 2022 Sep; 107(3):123-132. PubMed ID: 35995712
[TBL] [Abstract][Full Text] [Related]
49. Serum levels of tumor necrosis factor-alpha in patients with psoriasis before, during and after narrow-band UVB phototherapy.
Rossi MT; Venturini M; Zanca A; Arisi M; Fusano M; Sottini A; Serana F; Imberti L; Calzavara-Pinton P
G Ital Dermatol Venereol; 2018 Feb; 153(1):1-4. PubMed ID: 28704992
[TBL] [Abstract][Full Text] [Related]
50. Narrow-band UVB effects on cutaneous vitamin D receptor expression and serum 25-hydroxyvitamin D in generalized vitiligo.
El-Hanbuli HM; Dawoud NM; Mahmoud RH
Photodermatol Photoimmunol Photomed; 2018 May; 34(3):175-183. PubMed ID: 29080365
[TBL] [Abstract][Full Text] [Related]
51. Current developments in phototherapy for psoriasis.
Morita A
J Dermatol; 2018 Mar; 45(3):287-292. PubMed ID: 29369396
[TBL] [Abstract][Full Text] [Related]
52. Therapeutic evaluation of UVB-targeted phototherapy in vitiligo that affects less than 10% of the body surface area.
Welsh O; Herz-Ruelas ME; Gómez M; Ocampo-Candiani J
Int J Dermatol; 2009 May; 48(5):529-34. PubMed ID: 19416388
[TBL] [Abstract][Full Text] [Related]
53. Narrow-band ultraviolet B radiation: a review of the current literature.
Bandow GD; Koo JY
Int J Dermatol; 2004 Aug; 43(8):555-61. PubMed ID: 15304175
[TBL] [Abstract][Full Text] [Related]
54. No Additional Benefit of Combining Fractional Carbon Dioxide Laser With Narrow-Band Ultraviolet B Phototherapy for Vitiligo: A Randomized Prospective Study With Half-Body Side Comparison.
Eşme P; Gür Aksoy G; Elçin G
Dermatol Surg; 2019 Dec; 45(12):1627-1634. PubMed ID: 30829772
[TBL] [Abstract][Full Text] [Related]
55. Medium-dose ultraviolet (UV) A1 vs. narrowband UVB phototherapy in atopic eczema: a randomized crossover study.
Gambichler T; Othlinghaus N; Tomi NS; Holland-Letz T; Boms S; Skrygan M; Altmeyer P; Kreuter A
Br J Dermatol; 2009 Mar; 160(3):652-8. PubMed ID: 19120333
[TBL] [Abstract][Full Text] [Related]
56. Dipeptidyl peptidase-4 inhibition and narrow-band ultraviolet-B light in psoriasis (DINUP): study protocol for a randomised controlled trial.
Lynch M; Ahern TB; Timoney I; Sweeney C; Kelly G; Hughes R; Tobin AM; O'Shea D; Kirby B
Trials; 2016 Jan; 17():29. PubMed ID: 26767505
[TBL] [Abstract][Full Text] [Related]
57. Serum 5-S-cysteinyldopa levels in patients with psoriasis undergoing narrowband ultraviolet B phototherapy.
Kikuchi K; Wakamatsu K; Tada Y; Komine M; Ito S; Tamaki K
Clin Exp Dermatol; 2008 Nov; 33(6):750-3. PubMed ID: 18954414
[TBL] [Abstract][Full Text] [Related]
58. Reduction of RANTES expression in lesional psoriatic skin after narrow band ultraviolet therapy: a possible marker of therapeutic efficacy.
Rateb AA; Fawzi MM; Abdel Hay RM; Mohammed FN; Amr KS
Eur J Dermatol; 2012; 22(4):481-7. PubMed ID: 22531960
[TBL] [Abstract][Full Text] [Related]
59. Narrow band UVB: is it effective and safe for paediatric psoriasis and atopic dermatitis?
Pavlovsky M; Baum S; Shpiro D; Pavlovsky L; Pavlotsky F
J Eur Acad Dermatol Venereol; 2011 Jun; 25(6):727-9. PubMed ID: 20726938
[TBL] [Abstract][Full Text] [Related]
60. A randomized comparison of excimer laser versus narrow-band ultraviolet B phototherapy after punch grafting in stable vitiligo patients.
Linthorst Homan MW; Spuls PI; Nieuweboer-Krobotova L; de Korte J; Sprangers MA; Bos JD; Wolkerstorfer A; van der Veen JP
J Eur Acad Dermatol Venereol; 2012 Jun; 26(6):690-5. PubMed ID: 21711467
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
